Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PI-2620 PET Tau Imaging in Individuals With Down Syndrome
2019-004634-41Phase 2Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jun 2020
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of 18F-PI-2620 (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: SUVR of 18F-PI-2620 PET images. Started Jun 2020; status: active.
02
Drugs
18F-PI-2620
Beyond the preview
Go deeper on 2019-004634-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004634-41.